Please note that the ASTRAL trial and its associated sub-studies closed to recruitment in October 2007.
Revascularisation: Randomise If Uncertain
The medical team should discuss any potentially eligible patient and consider whether it is appropriate for them to be randomised into the ASTRAL trial.
Note: Patients can be randomised as soon as consent is obtained. The assessment process and completion of the randomisation notepad should preferably occur within 4 weeks of the randomisation telephone call, otherwise assessment and randomisation should be deferred.